Scientific program

The following key issues of women's health at different stages of reproductive aging will be discussed at the conference:

• Molecular genetic, epigenetic, and immunological reasons of the reproductive system function impairment
• Determination of the women's reproductive system aging stages (STRAW+10 criteria) as the basis for the modern gynecological practice
• Genomic and non-genomic effects of endo- and exogenous sex hormones
• Cell technologies in gynecology
• Uterine bleeding in the context of modern drug therapy opportunities and latest recommendations
• Diagnosis of hyper- and androgen deficiency conditions and their correction
• Polycystic ovary syndrome: preservation of the reproductive function and health
• Impaired fat metabolism, metabolic syndrome and reproductive function
• Endocrinologic aspects of hormonal contraception
• Expansion of use of long-acting reversible contraceptives (LARC): global trend
• A "niche" of GnRH agonists/antagonists and sex hormones in gynecology
• Innovative therapies of uterine fibroids
• Endometriosis as a chronic inflammatory disease and principles of drug therapy
• The treatment of hyperplastic endometrial processes in view of recent recommendations
• Combined uterus pathology (uterine fibroids, adenomyosis, endometrial hyperplasia): focus on the uterus sparing
• Postmenopausal osteoporosis (therapeutic approaches)
• The role of hormones and metabolic disorders in the genesis of age-related osteoarthritis
• Genitourinary syndrome
• Gender differences in risk factors, course, and prevention of cardiovascular diseases: opportunities of MHT in view of recent evidence-based studies
• Menopause follow-up and MHT issues: consensus of the world's leading organizations
• MHT and gynecologic cancers
• Systemic MHT after preventive surgeries in BRCA gene mutation carriers
• The efficacy and safety of alternative therapy of menopausal disorders (SERM, TSEK, SSRI, SNRI, phytoestrogens, etc.)
• Various aspects of healthy aging and the role of a gynecologist